A forum for original data, hematological innovation, and evidence-based knowledge of primary clinical relevance. Program covers every hematologic subspecialty and includes satellite symposia, Updates-in-Hematology, and an exhibition organized by pharmaceutical companies and national and international non-profits.
First IPIG International
Statement of 10 March 2020 from the IPIG Board of Directors
The mission of the International PNH Interest Group is to advance optimal treatment and care of people living with paroxysmal nocturnal hemoglobinuria (PNH) and related conditions; to provide instruction, information, and training to health care providers; and to help further research on new and effective treatment options and improved patient access to approved therapies and treatments.